Center Laboratories Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Center Laboratories Inc with three other
companies in this sector in Taiwan:
Lotus Pharmaceutical Co.,Ltd.
sales of 6.42 billion Taiwanese Dollars [US$214.49 million]
of which 90%
was Western Medicine Manufacture),
Yungshin Global Holding Corp
(6.62 billion Taiwanese Dollars [US$221.13 million]
of which 73%
was Taiwan District), and
Grape King Bio Ltd
(9.39 billion Taiwanese Dollars [US$313.47 million]
of which 86%
was Direct Sales).
During the year ended December of 2017, sales at
Center Laboratories Inc were 19.39 billion Taiwanese Dollars (US$647.49 million).
increase of 28.9%
versus 2016, when the company's sales were 15.04 billion Taiwanese Dollars.
This was the fifth consecutive year of sales increases at Center Laboratories Inc
(and since 2012, sales have increased a total of 2,617%).
Sales of Dongyuan Segment saw an increase
46.8% in 2017, from
139.58 million Taiwanese Dollars to 204.93 million Taiwanese Dollars.
Not all segments of Center Laboratories Inc experienced an increase in sales in 2017:
sales of Biology Tech. Investment fell 11.1% to 1.52 million Taiwanese Dollars.
(However, this segment's sales were only a very small portion of the company's overall sales).
Center Laboratories Inc also experienced decreases in sales in
Other Department (down 11.1% to 106.79 million Taiwanese Dollars)